Mortality Hazard Associated with Anxiolytic and Hypnotic Drug Use in the National Population Health Survey
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Objective: Although widely used in the general population, sleeping pills and minor tranquilizers, also known as antianxiety agents, have been associated with undesirable outcomes. Reports about the association of these drugs with an elevated mortality rate are inconsistent and controversial. This study was designed to assess the mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey in Canada. It was hypothesized that anxiolytic and hypnotic drug use would be associated with an elevated mortality hazard. Method: A population-based sample of 14 117 people aged 18 to 102 years participated in a longitudinal panel survey, with data collected every second year from 1994 to 2007. The primary outcome measures reported in this study are self-report use of anxiolytic and hypnotic drugs, and death. Results: For respondents who reported anxiolytic or hypnotic drug use in the past month the odds of mortality were 3.22 times more (95% CI 2.70 to 3.84) than for those who did not use anxiolytic or hypnotic drugs in the past month. After controlling for confounding sociodemographic, lifestyle, and health factors (including depression), the odds ratio was reduced to 1.36 (95% CI 1.09 to 1.70) but remained significant. Conclusion: Sedative drug use is associated with a small but significant increase in mortality risk. Further research is required to confirm the mechanisms by which sedative drug use increases mortality risk. Where possible, physicians should systematically consider possibilities for nonpharmacological treatment of sleep disturbances and anxiety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Brief interventions 477 have included sending a letter to patients who are long-term benzodiazepine users suggesting they stop, [16][17][18][19] resulting in discontinuation rates between 10% and 24% at 6-month follow-up”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [16]
In the citing paper
“the discontinuation rate in our control group was higher than in similar studies. 14,16,18,20,36”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [16]
Citations
Cites
Freeman, A. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1112 · Cited by 1,666
Mortality Associated With Sleep Duration and Insomnia
Kripke, D. F., Garfinkel, L., Wingard, D. L., Klauber, M. R., & Marler, M. R. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.2.131 · Cited by 1,614 · cited 1×
“The mortality rate remained significantly high even after controlling for insomnia and reported sleep duration.(12) Depressive symptoms, particularly suicide attempts, are potential confounds in the relation between sedative drug use and mortality.”
Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004)
Morin, C. M., Bootzin, R. R., Buysse, D. J., Edinger, J. D., Espie, C. A., & Lichstein, K. L. (2006) · Sleep · doi:10.1093/sleep/29.11.1398 · Cited by 1,345
MORIN, C., LEBLANC, M., DALEY, M., GREGOIRE, J., & MERETTE, C. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.08.008 · Cited by 1,191 · cited 1×
“Finally, natural products and over-the-counter medications are frequently used to self-treat anxiety and insomnia.(22) Although little is known about the safety of short- or long-term use of these medications, Rumble and Morgan(17) observed a higher mortality risk in users of analgesics and over-the-counter medication…”
Insomnia and Its Treatment: Prevalence and Correlates
Mellinger, G. D. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260019002 · Cited by 1,071
Psychotropic Drug Use and the Risk of Hip Fracture
Ray, W. A., Griffin, M. R., Schaffner, W., Baugh, D. K., & Melton, L. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160702 · Cited by 1,000
Albeck, J. H. (2001) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.2001.55.2.295 · Cited by 973
Treatment of specific phobia in adults
Choy, Y., Fyer, A. J., & Lipsitz, J. D. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.10.002 · Cited by 571
Cognitive Effects of Long-Term Benzodiazepine Use: A Meta-Analysis
Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004) · CNS Drugs · doi:10.2165/00023210-200418010-00004 · Cited by 552
Fergusson, D., Doucette, S., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., & Hutton, B. (2005) · BMJ · doi:10.1136/bmj.330.7488.396 · Cited by 510
Psychoactive Drugs and the Risk of Injurious Motor Vehicle Crashes in Elderly Drivers
Ray, W. A., Fought, R. L., & Decker, M. D. (1992) · American Journal of Epidemiology · doi:10.1093/aje/136.7.873 · Cited by 417
Sertraline Treatment of Pathological Gambling: A Pilot Study
Saiz-Ruiz, J., Blanco, C., Ibáñez, A., Masramon, X., Gómez, M. M., Madrigal, M., & Díez, T. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0104 · Cited by 293
Insomnia and its treatment: When are hypnotics justified?
Malcolm, R., & Gross, J. A. (1984) · Postgraduate Medicine · doi:10.1080/00325481.1984.11698665 · Cited by 290
Robinson, J., Sareen, J., Cox, B. J., & Bolton, J. (2009) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2008.03.013 · Cited by 213
Ten-Year Trends in the Pharmacological Treatment Of Insomnia
Reid1, K., & Dawson, D. (1999) · Sleep · doi:10.1093/sleep/22.3.371 · Cited by 189
Mortality Hazard Associated with Prescription Hypnotics
Kripke, D. F., Klauber, M. R., Wingard, D. L., Fell, R. L., Assmus, J. D., & Garfinkel, L. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00292-8 · Cited by 184
Beyond Benzodiazepines: Alternative Pharmacologic Agents for the Treatment of Insomnia
Wagner, J., Wagner, M. L., & Hening, W. A. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17111 · Cited by 161
Benzodiazepines, breathing, and sleep
Guilleminault, C. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90282-i · Cited by 160
The Epidemiology of Long-Term Benzodiazepine Use
Neutel, C. I. (2005) · International Review of Psychiatry · doi:10.1080/09540260500071863 · Cited by 148
Chronic hypnotic use: deadly risks, doubtful benefit
Kripke, D. F. (2000) · Sleep Medicine Reviews · doi:10.1053/smrv.1999.0076 · Cited by 147
Prevalence of insomnia in elderly general practice attenders and the current treatment modalities
Hohagen, F., Käppler, C., Schramm, E., Rink, K., Weyerer, S., Riemann, D., & Berger, M. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01563.x · Cited by 140
Review: Bupropion and SSRI-induced side effects
Demyttenaere, K., & Jaspers, L. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107083798 · Cited by 132
Hypnotics, Sleep, and Mortality in Elderly People
Morgan, K. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01850.x · Cited by 125
Benzodiazepine Use and Driving: A Meta-Analysis
Rapoport, M. J., Lanctôt, K. L., Streiner, D. L., Bédard, M., Vingilis, E., Murray, B., Schaffer, A., Shulman, K. I., & Herrmann, N. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04325 · Cited by 125
Is usage of hypnotics associated with mortality?
Mallon, L., Broman, J., & Hetta, J. E. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2008.12.004 · Cited by 101
Psychotropic Medication and Insomnia Complaints in Two Epidemiological Studies
Ohayon, M. M., & Caulet, M. (1996) · The Canadian Journal of Psychiatry · doi:10.1177/070674379604100711 · Cited by 100
Greater incidence of depression with hypnotic use than with placebo
Kripke, D. F. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-42 · Cited by 96
(2005) · PubMed · Cited by 93
Psychological Treatments for Social Phobia
Rowa, K., & Antony, M. M. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000603 · Cited by 65
Meta-Analyses of Hypnotics and Infections: Eszopiclone, Ramelteon, Zaleplon, and Zolpidem
Joya, F. L., Kripke, D. F., Loving, R. T., Dawson, A., & Kline, L. E. (2009) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27552 · Cited by 62
Use of anxiolytic or hypnotic drugs and total mortality in a general middle‐aged population
Hausken, A. M., Skurtveit, S., & Tverdal, A. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1417 · Cited by 53
Possibility that certain hypnotics might cause cancer in skin
KRIPKE, D. F. (2008) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2008.00685.x · Cited by 47
Allgulander, C., Ljungberg, L., & Fisher, L. D. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02828.x · Cited by 45
Trends in Antidepressant Utilization From 2001 to 2004
Harman, J. S., Edlund, M. J., & Fortney, J. C. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.5.611 · Cited by 37
Allgulander, C., & Näsman, P. (1991) · Psychosomatic Medicine · doi:10.1097/00006842-199101000-00009 · Cited by 34
Treating generalized anxiety disorder with cognitive-behavioral therapy.
Lang, A. J. (2004) · PubMed · Cited by 22
Research works printed but not linked: 3
- Kish L., 1988, Surv Methodol, 14, 19
- Statistics Canada, 2008, National Population Health Survey (NPHS) [Internet]
- Lang AJ, 2004, J Clin Psychiatry, 65, S14
Cited by
Hypnotics' association with mortality or cancer: a matched cohort study
Kripke, D. F., Langer, R. D., & Kline, L. E. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000850 · Cited by 408
Weich, S., Pearce, H. L., Croft, P., Singh, S., Crome, I., Bashford, J., & Frisher, M. (2014) · BMJ · doi:10.1136/bmj.g1996 · Cited by 259
Malik, S., Kanwar, A., Sim, L. A., Prokop, L. J., Wang, Z., Benkhadra, K., & Murad, M. H. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-18 · Cited by 206
“behaviors [34-37].”
Vicens, C., Bejarano, F., Sempere, E., Mateu, C., Fiol, F., Socias, I., Aragonès, E., Palop, V., Beltran, J. L., Piñol, J. L., et al. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.134650 · Cited by 122
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
Kripke, D. F. (2016) · F1000Research · doi:10.12688/f1000research.8729.1 · Cited by 106
Metadata
- Authors
- Belleville, G.
- Affiliations
- Université Laval (CA)
- Corresponding author
- Belleville, Geneviève
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2010-09
- Volume
- 55
- Issue
- 9
- Pages
- 558-567
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- OpenAlex
- W2114235695
- Cited by
- 100
- References
- 36
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 6 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 9 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 10 · 2015: 12 · 2014: 10 · 2013: 6 · 2012: 8
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- The Canadian Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- anxiolytics, hypnotics, sedative drug use, mortality risk, minor tranquilizers, drug safety, sleep disorders, anxiety treatment, non-pharmacological treatment
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Canada, Female, Humans, Hypnotics and Sedatives, Longitudinal Studies, Male, Middle Aged, Mortality, Risk Factors, Socioeconomic Factors, Anti-Anxiety Agents, Confidence Intervals, Odds Ratio, Health Care Surveys, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.